Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
6,930.00
-40.00 (-0.57%)
At close: Sep 11, 2025
Daehan Nupharm Revenue
Daehan Nupharm had revenue of 49.87B KRW in the quarter ending June 30, 2025, a decrease of -7.88%. This brings the company's revenue in the last twelve months to 201.52B, down -0.35% year-over-year. In the year 2024, Daehan Nupharm had annual revenue of 202.19B, down -1.00%.
Revenue (ttm)
201.52B
Revenue Growth
-0.35%
P/S Ratio
0.48
Revenue / Employee
883.85M
Employees
228
Market Cap
96.98B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 202.19B | -2.04B | -1.00% |
Dec 31, 2023 | 204.22B | 6.27B | 3.16% |
Dec 31, 2022 | 197.96B | 31.37B | 18.83% |
Dec 31, 2021 | 166.59B | 17.29B | 11.58% |
Dec 31, 2020 | 149.29B | 15.20B | 11.33% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.16T |
Samsung Biologics | 5,031.69B |
Hanwha Aerospace | 19.25T |
Hyundai Motor Company | 182.25T |
HD Hyundai Heavy Industries | 15.58T |
KB Financial Group | 14.92T |